HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Folch, H. Articles by Waksman, B. H. Search for Related Content PubMed Articles by Folch, H. Articles by Waksman, B. H.

Regulation of Lymphocyte Responses in Vitro

III. Inhibition by Adherent Cells of the T-Lymphocyte Response to Phytohemagglutinin¹

Department of Microbiology, Yale University, New Haven, Connecticut 06510

Abstract

Depletion of adherent cells causes decreased synthesis of DNA by normal rat lymph node cells (LNC) stimulated with phytohemagglutinin (PHA). Purified peritoneal (PE) macrophages restore normal reactivity to low doses of PHA but depress the reaction at higher PHA levels or at higher macrophage concentrations (5%). With spleen cells, removal of adherent cells results in a marked increase of the response, and the addition of PE macrophages does not return it to the normal level. Spleen cells also show a clear-cut inhibition of thymidine incorporation at cell concentrations greater than 1 x 10⁶/ml. This "suppressor" effect disappears when adherent cells are removed, resulting in a linear dose-response curve with increasing cells similar to that of LNC. The existence of an adherent suppressor cell distinct from the macrophage is therefore postulated.

Footnotes

¹ This work was supported by United States Public Health Service Research Grants AI-06112 and AI-06455.

² On leave of absence from the Department of Experimental Medicine, Universidad Austral de Chile, Valdivia, Chile. Dr. Folch was supported by World Health Organization Research Training Grant M8/181/4/F.34.

³ On leave of absence from the Department of Pathology, University of Kumamoto Medical School, Kumamoto, Japan. Dr. Yoshinaga was supported by National Institutes of Health Foreign Fellowship F05-TW-1708.